Executive Board

The Berlin Institute of Health is led by an Executive Board, responsible for strategic planning and implementation of the research program. The Board consists of five members: the CEO, the CFO, the Chairman of the Board of Directors of the Charité, the Dean of the Medical Faculty of the Charité and the Scientific Director of the Max Delbrück Center for Molecular Medicine in the Helmholtz Association.

Since October 2020 Professor Christopher Baum has been the new Chief Executive Officer of BIH, replacing Professor Axel Radlach Pries after two years. More information about Professor Baum can be found in his curriculum vitae.

 

Prof. Dr. Christopher Baum
Chief Executive Officer
Berlin Institute of Health

Andrea Runow
Chief Financial Officer (interim)
Berlin Institute of Health

Prof. Dr. Axel Radlach Pries
Dean of the Charité - Universitätsmedizin Berlin

Prof. Dr. Heyo Kroemer
Charité – Universitätsmedizin Berlin

Prof. Dr. Thomas Sommer (kommissarisch)
Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft